Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

The Effect of Ruboxistaurin on Visual Loss in Patients with Moderately Severe to Very Severe Nonproliferative Diabetic Retinopathy. Initial Results of the Protein Kinase C Beta Inhibitor Diabetic Retinopathy Study (PKC-DRS) Multicenter Randomized Clinical Trial

The Effect of Ruboxistaurin on Visual Loss in Patients with Moderately Severe to Very Severe Nonproliferative Diabetic Retinopathy. Initial Results of the Protein Kinase C Beta Inhibitor Diabetic Retinopathy Study (PKC-DRS) Multicenter Randomized Clinical Trial. Diabetes. 2005; 54:2188-2197.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.